论文部分内容阅读
目的:探讨喜炎平注射液联合思密达治疗小儿轮状病毒肠炎的临床疗效。方法:回顾性分析我院自2014年10月~2015年6月间接受诊治的100例小儿轮状病毒肠炎患者,随机分为对照组和治疗组各50例,两组均采取常规输液综合方法治疗,对照组采用利巴韦林治疗,治疗组采用喜炎平注射液联合思密达治疗,比较两组患者经过治疗后症状改善情况。结果:经过治疗,治疗组的临床治疗有效率明显高于对照组,两组差异有统计学意义(P<0.05);治疗组患儿症状有效好转时间及住院时间均短于对照组,差异均有显著性意义(P<0.05)。结论:在小儿轮状病毒肠炎中,喜炎平联合思密达临床疗效好,副作用小,值得在临床推广应用。
Objective: To investigate the clinical effect of Xiyanping injection combined with Smecta in the treatment of pediatric rotavirus enteritis. Methods: A retrospective analysis of 100 cases of infantile rotavirus enteric disease in our hospital from October 2014 to June 2015 were randomly divided into control group and treatment group (50 cases each). Both groups were treated by routine infusion method The patients in the control group were treated with ribavirin. The patients in the treatment group were treated with Xiyanping Injection combined with Smectite. The symptoms of the two groups were compared after treatment. Results: After treatment, the effective rate of clinical treatment in the treatment group was significantly higher than that in the control group, with significant difference between the two groups (P <0.05); the effective transit time and hospital stay in the treatment group were shorter than those in the control group There was significant (P <0.05). Conclusion: In pediatric rotavirus enteritis, Xiyanping combined with Smectite has good clinical efficacy and small side effects, which is worthy of clinical application.